A metabolic enzyme plays a crucial role in vascular development and may be a good target for cancer therapies.

The breast cancer drug tamoxifen improves cognitive performance in post-menopausal women.

The protein CK1 delays cell division to avoid the generation of defects that drive tumorigenesis.

A protein kinase linked to inflammation and tumor development may be a good target for gastric cancer therapies.

Developmental biologist Chin Chiang, Ph.D., and his colleagues have discovered that Purkinje neurons in the cerebellum act as central regulators of neuronal development.

The director of the National Cancer Institute, Harold Varmus, M.D., told an overflow crowd at this year’s Orrin Ingram Distinguished Lecture that he is concerned about the climate for discovery research in the United States.